Bio-Techne (TECH) revenue

Revenue · fiscal 2026
$1.22B

Bio-Techne (TECH) reported revenue of $1.22B in fiscal 2026 (the year ended June 30, 2026). That is 0.4% lower than the $1.22B of fiscal 2025. Figures as of 18 Nov 2026, 07:40 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2026
$1.22B
Change on fiscal 2025
−0.4%
Growth, 5 years
+5.5% a year
Growth, 10 years
+9.3% a year
Highest on record
$1.22Bfiscal 2025
Lowest on record
$263.96Mfiscal 2009
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Techne revenue, in more detail

Over the five fiscal years to 2026 revenue grew at a compound 5.5% a year; over ten years the rate was 9.3% a year. Across the 18 fiscal years on record (2009–2026), the highest was $1.22B in fiscal 2025 and the lowest $263.96M in fiscal 2009.

History · 18 fiscal years

Revenue by fiscal year

Bio-Techne revenue, year by year

Bio-Techne (TECH) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2026$1.22B 0.4% down
2025$1.22B 5.2% up
2024$1.16B 2.0% up
2023$1.14B 2.8% up
2022$1.11B 18.7% up
2021$931.03M 26.0% up
2020$738.69M 3.5% up
2019$714.01M 11.0% up
2018$642.99M 14.2% up
2017$563.00M 12.8% up
2016$499.02M 10.3% up
2015$452.25M 26.4% up
2014$357.76M 15.2% up
2013$310.58M 1.3% down
2012$314.56M 8.5% up
2011$289.96M 7.8% up
2010$269.05M 1.9% up
2009$263.96M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Bio-Techne and comparable companies
CompanyRevenueFiscal year
DaVita DVA$13.64B2025
Halozyme Therapeutics HALO$1.40B2025
Universal Health Services UHS$17.36B2025
Repligen RGEN$738.26M2025
Bio-Techne TECH$1.22B2026
BioMarin Pharmaceutical BMRN$3.22B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TECH

Bio-Techne, figure by figure

Bio-Techne (TECH) overview: price, valuation and scorecardAll health care companies by market value

Bio-Techne revenue: questions and answers

What is Bio-Techne's revenue?

Bio-Techne (TECH) reported revenue of $1.22B in fiscal 2026 (the year ended June 30, 2026). That is 0.4% lower than the $1.22B of fiscal 2025.

What is the growth rate of Bio-Techne's revenue?

Over the five fiscal years to 2026 revenue grew at a compound 5.5% a year; over ten years the rate was 9.3% a year.

What are the highest and lowest revenue figures on record for Bio-Techne?

Across the 18 fiscal years on record (2009–2026), the highest was $1.22B in fiscal 2025 and the lowest $263.96M in fiscal 2009.

How is Bio-Techne's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Techne (TECH) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/TECH/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.